(HealthDay)—In a clinical practice guideline issued by the American Society of Colon and Rectal Surgeons and published in the September issue of Diseases of the Colon & Rectum, recommendations are presented for the management ...
Aug 23, 2021
0
34
Here's one more lesson from the COVID-19 pandemic: It appears safe to relax restrictions on methadone, the oldest and most stigmatized treatment drug for opioid addiction.
Aug 12, 2021
0
2
New tailored therapies offer exciting prospects for treating acute myeloid leukemia (AML), but taking advantage of them may require waiting a week or more for genetic testing before starting treatment, posing a dilemma for ...
Jun 4, 2020
0
0
(HealthDay)—A gene expression signature can identify T-cell mediated rejection (TCMR) ahead of time in kidney transplant recipients, according to a study published online March 1 in EBioMedicine.
Mar 6, 2019
0
7
Patients who took statins less than 70 percent of the time had a 20 percent increase in mortality compared with those taking them at least 90 percent of the time, a Stanford study found.
Feb 22, 2019
1
130
"Adherence clubs" can help people living with HIV stick to their medication regimens, according to research presented at the Conference on Retroviruses and Opportunistic Infections in Boston.
Feb 26, 2016
0
4
A marker commonly used to determine if a patient is having a heart attack can also be used to identify stable patients at high risk for deadly cardiac events, according to a new study led by investigators at Brigham and Women's ...
Aug 12, 2015
0
9
(HealthDay)—For postangiography patients, metabolic syndrome is associated with increased mortality, especially in patients with stable angina, according to a study published in the Feb. 1 issue of The American Journal ...
Jan 22, 2015
0
2
Despite high hopes that a blood pressure-lowering medication called aliskiren would help people following hospitalization for heart failure, no beneficial effects were found, according to research presented today at the American ...
Mar 12, 2013
0
0
According to new research from Brigham and Women's Hospital (BWH), adding vorapaxar, an investigational platelet blocker, to standard antiplatelet therapy significantly reduces the long-term risk of recurrent cardiovascular ...
Aug 27, 2012
0
0
